Cutaneous T-cell lymphoma.
Copyright policy )Cutaneous T-cell lymphoma.
Cutaneous T-cell lymphoma (CTCL) represents a spectrum of the non-Hodgkin's lymphomas, including mycosis fungoides (MFs) and Sezary syndrome. Although an uncommon malignancy, the number of new cases per year in the United States is increasing at a constant rate. This paper provides an overview of CTCL, including pathophysiology, information on the various treatment modalities, and practical clinical approaches needed by oncology nurses to assist individuals experiencing treatment-related toxicities. Psychosocial issues, an aspect of disease in which oncology nurses can provide support and understanding, also are addressed.
Patient Education as Topic, Radiotherapy, Administration, Topical, Interferon Type I, Antibodies, Monoclonal, Humans, Antineoplastic Agents, Infusions, Intravenous, PUVA Therapy, Lymphoma, T-Cell, Cutaneous, Neoplasm Staging
Patient Education as Topic, Radiotherapy, Administration, Topical, Interferon Type I, Antibodies, Monoclonal, Humans, Antineoplastic Agents, Infusions, Intravenous, PUVA Therapy, Lymphoma, T-Cell, Cutaneous, Neoplasm Staging
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!